Skip to main content
Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
144.46
-2.08 (-1.42%)
Dec 20, 2024, 4:00 PM EST - Market closed

Repligen Revenue

Repligen had revenue of $154.87M in the quarter ending September 30, 2024, with 9.69% growth. This brings the company's revenue in the last twelve months to $633.51M, down -2.91% year-over-year. In the year 2023, Repligen had annual revenue of $632.36M, down -21.11%.

Revenue (ttm)
$633.51M
Revenue Growth
-2.91%
P/S Ratio
12.74
Revenue / Employee
$355,307
Employees
1,783
Market Cap
8.09B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023632.36M-169.17M-21.11%
Dec 31, 2022801.54M131.00M19.54%
Dec 31, 2021670.53M304.27M83.08%
Dec 31, 2020366.26M96.02M35.53%
Dec 31, 2019270.25M76.21M39.28%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Walgreens Boots Alliance 147.66B
Henry Schein 12.50B
The Ensign Group 4.11B
Bruker 3.24B
Teleflex 3.03B
Chemed 2.38B
HealthEquity 1.15B
Ascendis Pharma 365.19M
Revenue Rankings

RGEN News

More News